US Patent 10550099 Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors
Patent 10550099 was granted and assigned to FORMA Therapeutics on February, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 1, 2019
0
Date of Patent
February 4, 2020
0
Patent Applicant
Patent Application Number
16290328
0
Patent Citations
Patent Citations Received
Patent Inventor Names
Susan Ashwell
0
Wei Lu
0
Zhongguo Wang
0
Ann-Marie Campbell
0
Anna Ericsson
0
David R. Lancia, Jr.
0
Gary Gustafson
0
Jian Lin
0
Justin Andrew Caravella
0
R. Bruce Diebold
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10550099 Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
